Low Serum Uric Acid Level Is a Risk Factor for Death in Incident Hemodialysis Patients

Background: A reverse epidemiology of classic cardiovascular risk factors was observed in hemodialysis patients with a high comorbidity burden. We hypothesized that uric acid, a novel cardiovascular risk factor, also has an altered association with survival in these patients. Methods: A retrospective study was conducted on 168 consecutive outpatient hemodialysis patients over a 6-year period. Serum uric acid, albumin levels and relevant laboratory information were recorded monthly. The disease severity was assessed using Comorbidity Index (CoI) scores. Patients were stratified into 3 groups according to their serum uric acid concentrations: group I was the lowest quintile, group II was the middle 3 quintiles and group III was the highest quintile. The risks of death were calculated utilizing a Cox regression model. Results: Using group II as a reference group, the hazard ratio of group I was 2.23 [95% confidence interval (CI) 1.21–4.11, p = 0.01] and group III was 0.89 (95% CI 0.47–1.71, p = 0.74). The serum uric acid levels correlated inversely with CoI scores (r = –0.31, 95% CI –0.44 to –0.17, p < 0.0001) and positively with serum albumin levels (r = 0.35, 95% CI 0.21–0.48, p < 0.0001). Conclusion: Low serum uric acid is a mortality risk factor in incident hemodialysis patients with a high comorbidity burden and hypoalbuminemia.

[1]  S. Anker,et al.  Risk factor paradox in wasting diseases , 2007, Current opinion in clinical nutrition and metabolic care.

[2]  J. Carrero,et al.  Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite. , 2007, The American journal of clinical nutrition.

[3]  J. Carrero,et al.  J-shaped mortality relationship for uric acid in CKD. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  Carlos Iribarren,et al.  Body Mass Index and Risk for End-Stage Renal Disease , 2006, Annals of Internal Medicine.

[5]  V. Mužáková,et al.  Monitoring of antioxidant properties of uric acid in humans for a consideration measuring of levels of allantoin in plasma by liquid chromatography. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[6]  P. Stenvinkel Inflammation in end‐stage renal disease: The hidden enemy (Review Article) , 2006, Nephrology.

[7]  J. Kopple The phenomenon of altered risk factor patterns or reverse epidemiology in persons with advanced chronic kidney failure. , 2005, The American journal of clinical nutrition.

[8]  N. Levin,et al.  Mortality among hemodialysis patients in Europe, Japan, and the United States: case-mix effects. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  Mei-Fen Pai,et al.  Serum uric acid levels show a 'J-shaped' association with all-cause mortality in haemodialysis patients. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  K. Tuttle,et al.  Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? , 2003, Hypertension.

[11]  K. Kalantar-Zadeh,et al.  Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. , 2003, Kidney international.

[12]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  B. Ames,et al.  Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[14]  G. Berti,et al.  Use of 3,5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. , 1980, Clinical chemistry.

[15]  L. B. Sorensen Role of the intestinal tract in the elimination of uric acid. , 1965, Arthritis and rheumatism.

[16]  Kdoqi Disclaimer K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.